AAAAAA
Results: 26-46/46
Authors:
Knight, MK
Blute, ML
Citation: Mk. Knight et Ml. Blute, Incidental discovery of pelvic leiomyosarcoma at radial prostatectomy, J UROL, 163(6), 2000, pp. 1866-1866
Authors:
Leibovich, BC
Engen, DE
Patterson, DE
Pisansky, TM
Alexander, EE
Blute, ML
Bergstralh, EJ
Zincke, H
Citation: Bc. Leibovich et al., Benefit of adjuvant radiation therapy for localized prostate cancer with apositive surgical margin, J UROL, 163(4), 2000, pp. 1178-1182
Authors:
Blute, ML
Citation: Ml. Blute, Management of superficial transitional cell carcinoma in the intramural ureter: What to do? Editorial comment, J UROL, 163(3), 2000, pp. 747-747
Authors:
Pisansky, TM
Kozelsky, TF
Myers, RP
Hillman, DW
Blute, ML
Buskirk, SJ
Cheville, JC
Ferrigni, RG
Schild, SE
Citation: Tm. Pisansky et al., Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer, J UROL, 163(3), 2000, pp. 845-850
Authors:
Berry, R
Schaid, DJ
Smith, JR
French, AJ
Schroeder, JJ
McDonnell, SK
Peterson, BJ
Wang, ZY
Carpten, JD
Roberts, SG
Tester, DJ
Blute, ML
Trent, JM
Thibodeau, SN
Citation: R. Berry et al., Linkage analyses at the chromosome 1 Loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer, AM J HU GEN, 66(2), 2000, pp. 539-546
Authors:
Cheng, L
Pisansky, TM
Sebo, TJ
Leibovich, BC
Ramnani, DM
Weaver, AL
Scherer, BG
Blute, ML
Zincke, H
Bostwick, DG
Citation: L. Cheng et al., Cell proliferation in prostate cancer patients with lymph node metastasis:A marker for progression, CLIN CANC R, 5(10), 1999, pp. 2820-2823
Authors:
Seay, TM
Blute, ML
Zincke, H
Citation: Tm. Seay et al., Radical prostatectomy and early adjuvant hormonal therapy for pTxN+ adenocarcinoma of the prostate (vol 50, pg 833, 1997), UROLOGY, 54(4), 1999, pp. 772-772
Authors:
Ghavamian, R
Blute, ML
Bergstralh, EJ
Slezak, J
Zincke, H
Citation: R. Ghavamian et al., Comparison of clinically nonpalpable prostate-specific antigen-detected (cT1c) versus palpable (cT2) prostate cancers in patients undergoing radical retropubic prostatectomy, UROLOGY, 54(1), 1999, pp. 105-110
Authors:
Noel, AA
Gloviczki, P
Cherry, KJ
Bower, TC
Hallett, JW
Panneton, JM
Whitley, D
Blute, ML
Stanson, AW
Citation: Aa. Noel et al., Optimal management of abdominal aortic aneurysms and urologic malignancies: Benefits of simultaneous surgical treatment, VASC SURG, 33(6), 1999, pp. 603-609
Authors:
Blute, ML
Citation: Ml. Blute, Nephron sparing surgery for localized renal cell carcinoma: Impact of tumorsize on patient survival, tumor recurrence and TNM staging - Comment, J UROL, 162(6), 1999, pp. 1933-1933
Authors:
O'Leary, MP
Gee, WF
Holtgrewe, HL
Blute, ML
Cooper, TP
Meyer, JJ
Miles, BJ
Naslund, MJ
Nellans, RE
Thomas, R
Painter, MR
Blizzard, R
Fenninger, RB
Citation: Mp. O'Leary et al., 1998 American Urological Association Gallup Survey: Changes in physician practice patterns, treatment of ureteral stones and impact of managed care, J UROL, 162(5), 1999, pp. 1702-1704
Authors:
Dechet, CB
Sebo, T
Farrow, G
Blute, ML
Engen, DE
Zincke, H
Citation: Cb. Dechet et al., Prospective analysis of intraoperative frozen needle biopsy of solid renalmasses in adults, J UROL, 162(4), 1999, pp. 1282-1284
Authors:
Blute, ML
Zincke, H
Citation: Ml. Blute et H. Zincke, Pathological features and prognostic significance of prostate cancer in the apical section determined by whole mount histology, J UROL, 162(4), 1999, pp. 1391-1392
Authors:
Ghavamian, R
Bergstralh, EJ
Blute, ML
Slezak, J
Zincke, H
Citation: R. Ghavamian et al., Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alonefor pTxN+ prostate cancer: A matched comparison, J UROL, 161(4), 1999, pp. 1223-1227
Authors:
Ghavamian, R
Bergstralh, EJ
Blute, ML
Slezak, J
Zincke, H
Citation: R. Ghavamian et al., Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alonefor pTxN+ prostate cancer: A matched comparison - Reply, J UROL, 161(4), 1999, pp. 1227-1228
Authors:
Amling, CL
Lerner, SE
Martin, SK
Slezak, JM
Blute, ML
Zincke, H
Citation: Cl. Amling et al., Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer, J UROL, 161(3), 1999, pp. 857-862
Authors:
Ramakumar, S
Bhuiyan, J
Besse, JA
Roberts, SC
Wollan, PC
Blute, ML
O'Kane, DJ
Citation: S. Ramakumar et al., Comparison of screening methods in detection of bladder cancer, J UROL, 161(2), 1999, pp. 388-394
Authors:
Corica, FA
Iczkowski, KA
Cheng, L
Zincke, H
Blute, ML
Wendel, A
Sebo, TJ
Neumann, R
Bostwick, DG
Citation: Fa. Corica et al., Cystic renal cell carcinoma is cured by resection: A study of 24 cases with long-term followup, J UROL, 161(2), 1999, pp. 408-411
Authors:
Blute, ML
Citation: Ml. Blute, The value of upper tract cytology after transurethral resection of bladdertumor in patients with bladder transitional cell cancer - Editorial comment, J UROL, 161(1), 1999, pp. 79-80
Authors:
Cheng, L
Bergstralh, EJ
Scherer, BG
Neumann, RM
Blute, ML
Zincke, H
Bostwick, DG
Citation: L. Cheng et al., Predictors of cancer progression in T1a prostate adenocarcinoma, CANCER, 85(6), 1999, pp. 1300-1304
Authors:
Cheng, L
Bergstralh, EJ
Cheville, JC
Slezak, J
Corica, FA
Zincke, H
Blute, ML
Bostwick, DG
Citation: L. Cheng et al., Cancer volume of lymph node metastasis predicts progression in prostate cancer, AM J SURG P, 22(12), 1998, pp. 1491-1500